Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL – Get Free Report) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 10,900 shares, a decline of 6.0% from the May 31st total of 11,600 shares. Based on an average daily volume of 11,200 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.3% of the company’s stock are sold short.
Cryo-Cell International Price Performance
Shares of CCEL opened at $7.07 on Wednesday. Cryo-Cell International has a 52-week low of $3.67 and a 52-week high of $9.50. The company has a market capitalization of $57.27 million, a P/E ratio of 17.30 and a beta of 0.47.
Cryo-Cell International (NYSEAMERICAN:CCEL – Get Free Report) last released its earnings results on Monday, April 15th. The company reported $0.07 EPS for the quarter. The firm had revenue of $7.85 million for the quarter. Cryo-Cell International had a negative return on equity of 64.31% and a negative net margin of 31.02%.
Institutional Investors Weigh In On Cryo-Cell International
Cryo-Cell International Company Profile
Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.
See Also
- Five stocks we like better than Cryo-Cell International
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Generac Holdings Stock: Mixed Signals Leave Investors Uncertain
- 3 Tickers Leading a Meme Stock Revival
- Analysts and Earnings Propel the S&P 500’s Continuous Growth
- Quiet Period Expirations Explained
- CrowdStrike Stock Soars, Outpacing Palo Alto in Cybersecurity
Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with MarketBeat.com's FREE daily email newsletter.